Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Novel Food Application

6 Apr 2021 07:00

RNS Number : 4600U
Zoetic International PLC
06 April 2021
 

For immediate release

6 April 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

 

Zoetic International plc

('Zoetic', the 'Company' or the 'Group')

 

Zoetic's Novel Food Application passes FSA administrative check

 

Zoetic, the international CBD group, is pleased to provide the following update on its efforts to gain regulatory approval by the UK Food Standards Agency ('FSA' or the 'Agency') for its products in the United Kingdom. This FSA approval is now required for CBD products to be sold in the UK. This applies to all CBD brands and not only those owned by Zoetic.

 

Overview

· The FSA announced on 13 February 2020 that businesses must submit a novel food authorisation application by 31 March 2021 if they wish to have their CBD products sold in the UK. CBD products without the authorisation and subsequent validation would not be allowed to be sold in the UK.

 

· Zoetic submitted an application in conjunction with the European Industrial Hemp Association's ('EIHA') Novel Food Consortium.

 

· Zoetic received notification from EIHA that its CBD products passed the regulator's administrative check and can remain on sale in the UK.

 

· Official validation will be granted pending the results of toxicological studies on CBD, expected in the coming months.

 

Following the submission of a legal dossier, made in partnership with the EIHA's Novel Food Consortium, the Group has now received confirmation that its natural isolate CBD products can continue to be sold in the UK as the application has passed the regulator's administrative check. Official validation is expected to follow in the coming months, pending the results of toxicological studies of the CBD contained in its products.

 

Trevor Taylor, Co-CEO of Zoetic, said: "The FSA's regulation marks a pivotal moment for the CBD industry and Zoetic welcomes the Agency's efforts to protect consumers from CBD products that do not meet the necessary standards. We submitted our application with EIHA, a highly respected European industry association, and are thrilled that the submission has passed the initial check and we are now one step closer to full validation. As always, we are committed to rigorous quality assurance processes at every step because our success as a company is indivisible from the quality of our products."

 

Further progress is expected in the coming months. More information can be found on the EIHA website.

 

- Ends -

 

About the European Industrial Hemp Association

The European Industrial Hemp Association ('EIHA') represents the collective interests of key stakeholders in the hemp industry across the European Union ('EU'). Their primary function is to advocate for the industry by contributing to international policy-making consultations and decisions by European regulators. EIHA also operates a Novel Food Consortium which aims to secure the necessary regulatory approvals for members to continue producing and selling their products.

 

Publication on website

 

A copy of this announcement is also available on the Group's website at www.zoeticinternational.com

 

Media enquiries:

Zoetic International plc

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

 

Nick Naylor (Corporate Finance)

 

Guy McDougall (Equity Sales)

 

 

 

Buchanan

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

Tel: +44 (0) 20 7466 5000

zoetic@buchanan.uk.com

www.buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKPBDDBKBKQK
Date   Source Headline
15th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 201610:15 amRNSDisposal of Warrants and Interest in Shares
15th Jun 20167:53 amRNSFinal Results
15th Jun 20167:50 amRNSHelios Two Transaction
14th Jun 201612:30 pmRNSIssue of Shares
10th Jun 20167:00 amRNSDT Ultravert Update
8th Jun 20167:00 amRNSAcquisition of Helium Licences in Montana
6th Jun 201611:34 amRNSInterest in Shares
31st May 20167:00 amRNSIssue of Shares
23rd May 20167:00 amRNSLicence Agreement with Calfrac for DT UltraVert
20th May 20167:00 amRNSIncreases Uranium Acreage in Utah
20th May 20167:00 amRNSIssue of Shares
18th May 20169:00 amRNSFurther Acquisition of Licences in North Dakota
13th May 20167:00 amRNSIssue of Shares
9th May 20167:00 amRNSIssue of Shares
5th May 20164:40 pmRNSSecond Price Monitoring Extn
5th May 20164:35 pmRNSPrice Monitoring Extension
5th May 20167:00 amRNSIssue of Shares
28th Apr 20161:00 pmRNSIssue of Shares
27th Apr 201612:45 pmRNSResults of General Meeting
27th Apr 20167:00 amRNSShare Subscription Raises £519,093
25th Apr 20167:49 amRNSCorporate Update
1st Apr 20168:00 amRNSPublication of Circular and Notice of GM
30th Mar 20167:00 amRNSDoubles Utah Uranium Acreage
18th Mar 20162:45 pmRNSSigns Agreement for Potential Uranium Discovery
15th Mar 20167:00 amRNSIssue of Shares
11th Mar 20167:00 amRNSIssue of Shares
22nd Feb 20167:00 amRNSIssue of Shares
17th Feb 20167:00 amRNSIssue of Shares
11th Feb 201610:00 amRNSIssue of Shares
3rd Feb 20168:30 amRNSReadmission to Trading on London Stock Exchange
29th Jan 20167:00 amRNSPublication of Prospectus; Readmission; Placing
27th Nov 20157:00 amRNSInterim Results
16th Nov 20157:00 amRNSAcquires Leasehold Interest
25th Sep 20157:00 amRNSLicence Agreement with Schlumberger
19th Aug 20157:00 amRNSAppointment of Financial Adviser and Broker
30th Jun 20154:04 pmRNSHolding(s) in Company
25th Jun 20157:42 amRNSSuspension
25th Jun 20157:25 amRNSSuspension of Trading
29th May 20157:00 amRNSIssue of Equity
26th May 20157:01 amRNSCompletes Oilfield Technology Acquisition
12th May 20157:00 amRNSStrategy Update & Oilfield Technology Acquisition
25th Mar 20158:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.